ClinicalTrials.gg
Status unknownNCT02973178Updated Nov 25, 2016

Scanadu Urine Device Validation Study Protocol

An interventional study of Scanadu Urine Device in Urinary Tract Infections, Proteinuria and Ketone Urine, sponsored by Scanadu, Inc.. Status unknown at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-11-25.

Sponsored by Scanadu, Inc. · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Nov 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will test Scanadu Urine Device for clinical performance and usability.

Read the detailed description

The objectives of this study are to:

  • Evaluate and validate the clinical performance of the Scanadu Urine Device in the hands of intended users as compared to: the visual read of chemical test strips performed by lab technicians utilizing the Siemens Multistix® 10SG technology (K905396).
  • Evaluate and validate the user-interface of the Scanadu Urine Device by the intended users for human factors and user interface of the Scanadu Urine Device.
  • Evaluate the reproducibility in the hands of the lay-users after repeated testing of samples with known test levels
02

Conditions studied

  • Urinary Tract Infections
  • Proteinuria
  • Ketone Urine
  • Hematuria
  • Glucose Intolerance
03

In context

Urinary Tract Infections

779 studies on the registry are indexed under Urinary Tract Infections; 132 are open to participants now.

This study's planned enrollment of 300 is above the median of 130 across 544 interventional studies indexed under Urinary Tract Infections.

Browse Urinary Tract Infections studies →

Lead sponsor

This is the only study on the registry with Scanadu, Inc. as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female and male
  • 18 years old or older
  • Pregnant or not pregnant
  • Must have experience using an Apple iPhone
  • Have no visual impairments
  • Able to hold Smart Phone horizontally in raised dominant hand
  • Must be able to read and understand English
  • Must provide Informed Consent

Exclusion criteria

Exclusion Criteria:

  • Has a known history of a visual impairment that may affect reading and navigating the Scanadu Urine app
  • Unable to void and collect urine specimen for testing
  • Unable to hold phone steady (horizontally) or has history of tremors or conditions such as Parkinson's disease
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
300 participants (estimated)

Study arms

  • Other
    Usability

    Evaluate and validate the user-interface of the Scanadu Urine Device by the intended users for human factors and user interface of the Scanadu Urine Device.

    Device: Scanadu Urine Device

  • Active comparator
    Method Comparison

    Evaluate and validate the clinical performance of the Scanadu Urine Device in the hands of intended users as compared to: * The visual read of chemical test strips performed by lab technicians utilizing the Siemens Multistix® 10SG technology (K905396), * Scanadu Urine Device tests performed by lab technicians.

    Device: Scanadu Urine Device

  • Other
    Reproducibility

    Evaluate the reproducibility in the hands of the lay-users after repeated testing of samples with known test levels.

    Device: Scanadu Urine Device

Interventions

  • DeviceScanadu Urine Device

    Device to allow lay user to perform urinalysis test at home.

06

What researchers measure

Primary outcomes

  1. Usability: % successful scans in three tests conducted by lay users in following the app on the iPhone and obtain user experience on questionnaire

    Evaluate and validate the user-interface of the Scanadu Urine Device by the intended users for human factors and user interface of the Scanadu Urine Device.

    Time frame: Single visit in one day

  2. Method Comparison: Conduct two tests by following iPhone app (self and patient samples), results in concordance with professional testers; achieve accuracy in different concentrations of six urine analytes each using approximately 20 samples per level.

    Evaluate and validate the clinical performance of the Scanadu Urine Device in the hands of intended users as compared to: the visual read of chemical test strips performed by lab technicians utilizing the Siemens Multistix® 10SG technology (K905396).

    Time frame: Single visit in one day

  3. Reproducibility: Lay user's ability to repeat a urine test nine times by following iPhone app and obtain nine results that are in concordance.

    Evaluate the reproducibility in the hands of the lay-users after repeated testing of samples with known test levels

    Time frame: Single visit in one day

07

Study locations

1 of 2 sites recruiting
  • West Coast Research, LLC
    Mountain View, California 94040, United States
    • Tim Davis · Contact · 925-413-1451
    • Jenny Li · Contact · 650-567-6389
    Recruiting
  • West Coast Research, LLC
    San Leandro, California 94577, United States
    Completed
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02973178
Lead sponsor
Scanadu, Inc.
Responsible party
Sponsor
First posted
Nov 25, 2016
Start date
Aug 2016
Primary completion
Dec 2016 (estimated)
Completion
Dec 2016 (estimated)
Last update
Nov 25, 2016

Study contacts

Jenny Li
Contact
jenny.li@scanadu.com
650-567-6389
Daya Ranamukhaarachchi
Contact
daya@scanadu.com
301-569-1213

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion